Total synthesis of the salicylate enamide macrolide oximidine III: Application of relay ring-closing metathesis

Angewandte Chemie - International Edition

Volumn 43, Issue 27, 2004, Pages 3601-3605

  Wang, Xiang ^a   Bowman, Emma Jean ^b   Bowman, Barry J ^b   Porco Jr , John A ^a  

^a Boston University   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antitumor agents; Enamides; Natural products; Ring closing metathesis; Vinyl iodides

Indexed keywords

HYDROGEN; POLYMERIZATION; STEREOCHEMISTRY; SUBSTRATES; SYNTHESIS (CHEMICAL);

ENAMIDE; MACROCYCLIZATION;

ADENOSINETRIPHOSPHATE;

ALKENE; AMIDE; EPOXIDE; IMIDE; MACROLIDE; OXIMIDINE III; SALICYLIC ACID DERIVATIVE; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; LACTONE;

ARTICLE; CHEMICAL ANALYSIS; CHEMICAL MODIFICATION; CHEMICAL REACTION KINETICS; CYCLIZATION; DRUG SYNTHESIS; ENANTIOSELECTIVITY; RING CLOSING METATHESIS; STEREOISOMERISM; CHEMISTRY; METABOLISM; SYNTHESIS;

AMIDES; ANTINEOPLASTIC AGENTS; EPOXY COMPOUNDS; LACTONES; MACROLIDES; SALICYLATES;

EID: 4143108202     PISSN: 14337851     EISSN: None     Source Type: Journal    
DOI: 10.1002/anie.200460042     Document Type: Article

References (44)

1. T. Nishi, M. Forgac, Nat. Rev. Mol. Cell Biol. 2002, 3, 94.
2. a) M. R. Boyd, C. Farina, P. Belfiore, S. Gagliardi, J. W. Kim, Y. Hayakawa, J. A. Beutler, T. C. McKee, B. J. Bowman, E. J. Bowman, J. Pharmacol. Exp. Ther. 2001, 297, 114;
3. b) for a recent review of syntheses and SAR studies, see: L. Yet, Chem. Rev. 2003, 103, 4283.
4. J. W. Kim, K. Shin-ya, K. Furihata, Y. Hayakawa, H. Seto, J. Org. Chem. 1999, 64, 153.
5. a) Y. Hayakawa, T. Tomikawa, K. Shin-Ya, N. Arao, K. Nagai, K-I. Suzuki, J. Antibiot. 2003, 56, 899;
6. b) Y. Hayakawa, T. Tomikawa, K. Shin-Ya, N. Arao, K. Nagai, K-I. Suzuki, K. Furihata, J. Antibiot. 2003, 56, 905.
7. For the total synthesis of oximidine II, see: a) X. Wang, J. A. Porco, Jr, J. Am. Chem. Soc. 2003, 125, 6040;
8. for recent studies on the synthesis of the oximidines, see: b) T. Haack, S. Kurtkaya, J. P. Snyder, G. I. Georg, Org. Lett. 2003, 5, 5019;
9. c) J. E. Harvey, S. A. Raw, R. J. K. Taylor, Tetrahedron Lett. 2003, 44, 7209.
10. a) R. Shen, J. A. Porco, Jr, Org. Lett. 2000, 2, 1333;
11. b) R. Shen, C. T. Lin, E. J. Bowman, B. J. Bowman, J. A. Porco, Jr, J. Am. Chem. Soc. 2003, 125, 7889;
12. for applications of this method, see: ref. [5a] and c) A. Fürstner, T. Dierkes, O. R. Thiel, G. Blanda, Chem. Eur. J. 2001, 7, 5286;
13. d) R. Shen, C. T. Lin, J. A. Porco, Jr, J. Am. Chem. Soc. 2002, 124, 5650;
14. e) K. C. Nicolaou, D. W. Kim, R. Baati, A. O'Brate, P. Giannakakou, Chem. Eur. J. 2003, 9, 6177;
15. f) R. S. Coleman, P.-H. Liu, Org. Lett. 2004, 6, 577;
16. g) Q. Su, J. S. Panek, J. Am. Chem. Soc, 2004, 126, 2425.
17. Recent reviews: a) A. Fürstner, Angew. Chem. 2000, 112, 3140; Angew. Chem. Int. Ed. 2000, 39, 3012;
18. Recent reviews: a) A. Fürstner, Angew. Chem. 2000, 112, 3140; Angew. Chem. Int. Ed. 2000, 39, 3012;
19. b) T. M. Trnka, R. H. Grubbs, Acc. Chem. Res. 2001, 34, 18;
20. c) for RCM with a vinyl epoxide, see: K. Yamamoto, K. Biswas, C. Gaul, S. J. Danishefsky, Tetrahedron Lett. 2003, 44, 3297.
21. Y. Wu, X. Liao, R. Wang, X.-S. Xie, J. K. De Brabander, J. Am. Chem. Soc. 2002, 124, 3245.
22. For an example of allylic substitution effects on reaction rates of RCM, see: T. R. Hoye, H. Zhao, Org. Lett. 1999, 1, 1123.
23. For studies regarding relay RCM, see: a) T. R. Hoye, J. Wang, 226th ACS National Meeting (New York, NY), 2003, ORGN-670;
24. b) T. R. Hoye, R. Thomas, H. Zhao, 218th ACS National Meeting, (New Orleans, LA), 1999, ORGN-620;
25. c) T. R. Hoye, H. Zhao, 218th ACS National Meeting (New Orleans, LA), 1999, ORGN-303;
26. d) for another application of a "relay" entity in the assembly of reacting sites in RCM, see: A. Fürstner, K. Langemann, Synthesis 1997, 792.
27. The chiral nonracemic epoxide 16 was prepared by hydrolytic kinetic resolution of the racemic epoxide (48% yield, 95% ee): S. E. Schaus, B. D. Brandes, J. F. Larrow, M. Tokunaga, K. B. Hansen, A. E. Gould, M. E. Furrow, E. N. Jacobsen, J. Am. Chem. Soc. 2002, 124, 1307.
28. T. Katsuki, V. S. Martin, Org. React. (N. Y.) 1996, 48, 1.
29. Use of a sterically demanding TBS protecting group on the secondary alcohol resulted in low diastereoselectivity of the Sharpless asymmetric epoxidation (4:1).
30. D. B. Dess, J. C. Martin, J. Org. Chem. 1983, 48, 4155.
31. J. W. Labadie, D. Tueting, J. K. Stille, J. Org. Chem. 1983, 48, 4634.
32. Use of the Grubbs first-generation catalyst led to the corresponding by-products 6 (Scheme 2).
33. S. B. Garber, J. S. Kingsbury, B. L. Gray, A. H. Hoveyda, J. Am. Chem. Soc. 2000, 122, 8168.
34. P. R. Blakemore, W. J. Cole, P. J. Kociénski, A Morley, Synthesis 1996, 285. For the preparation of 25, see the Supporting Information.
35. K. Takai, K. Nitta, K. Utimoto, J. Am. Chem. Soc. 1986, 108, 7408.
36. a) D. Seyferth, R. S. Marmor, P. Hilbert, J. Org. Chem. 1971, 36, 1379;
37. b) R. Ratcliffe, B. Christensen, Tetrahedron Lett. 1973, 14, 4645;
38. c) J. C. Gilbert, U. Weerasooriya, J. Org. Chem. 1982, 47, 1837;
39. d) D. G. Brown, E. J. Velthuisen, J. R. Commerford, R. G. Brisbois, T. R. Hoye, J. Org. Chem. 1996, 61, 2540.
40. For the preparation of 30, see the Supporting Information; a) for a related chloromethyl benzothiazole sulfone reagent, see: J. B. Baudin, G. Hareau, S. A. Julia, R. Lorne, O. Ruel, Bull. Soc. Chim. Fr. 1993, 130, 856;
41. b) for use of iodoalkyl phenyl sulfone reagents in free radical reactions, see: P. Jankowski, M. Masnyk, J. Wicha, Synlett 1995, 866.
42. 1H NMR analysis.
43. In our synthesis of oximidine II (ref. [5a]), we utilized a silylated phenol substrate treated with base and amide (2 equiv each) in a copper-mediated coupling to effect both silyl ether deprotection and enamide formation. However, use of excess base and amide in the syntheses described herein led to significant decomposition of the sensitive vinyl epoxide moiety.
44. V-ATPase activity was determined as described in the Supporting Information.